Nichi-Iko Pharmaceutical is off to a new start making the former Elmed Eisai its wholly owned subsidiary on April 1.…
ORGANIZATION
Think Tank Urges Govt to Look at Drugs with Large Prescription Volumes Too
The Institute for New Era Strategy (INES), a think tank headed by former Pfizer Japan President Ichiro Umeda, unveiled a list of proposals on January 23 calling for more focus on low-cost drugs that are prescribed in large volumes, rather…
To read the full story
Related Article
ORGANIZATION
- Number of Contract Sales Reps Down 11.5% in FY2018: JCSOA
April 19, 2019
- GHIT Fund to Leverage Japanese Technology to Benefit Neglected Patients around the World: New CEO
April 18, 2019
- Regenerative Medicine Groups in Asia Begin Discussions towards Mutual Approval
April 15, 2019
- JPMA Not Envisioning Asia-Version EMA at This Point: Chief
April 11, 2019
- Drug Damage Watchdog Nudges Govt, Shionogi to Suspend Xofluza Sales
April 10, 2019
Japan’s generic market is hitting a plateau soon. Incentive measures rolled out by the government since 2002 have driven its…
Manufacturers of regenerative medicine-based products are beginning to differentiate themselves from competitors based not only on efficacy but also on the reduction of burdens on medical institutions where their therapies are provided.The procedures required for administering regenerative medicine products are…
Japan is to not use its new cost-effectiveness assessment (CEA) scheme for reimbursement decisions - at least for now -…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…
With Japan’s tighter price control casting a chill over its pharma market, companies are setting their sights beyond the field of health insurance to carve out a new revenue stream, seeking opportunities in the business to tackle “mibyo” - a…